Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Louisiana Could Become First State to Classify Abortion-Inducing Drugs as Controlled Substances
05/13/2024
Hannah Musick
Louisiana legislators are considering classifying abortion-inducing drugs as controlled substances, potentially restricting access, criminalizing the use of the medication outside of a prescription, and impacting medical care beyond abortion.
Louisiana legislators are considering classifying abortion-inducing drugs as controlled substances, potentially restricting access, criminalizing the use of the medication outside of a prescription, and impacting medical care beyond abortion.
Louisiana legislators are...
05/13/2024
Pharmacy Learning Network
News
Subpotent Ophthalmic Solution Recalled
05/09/2024
Jolynn Tumolo
Imprimis NJOF is recalling 3320 bottles of compounded prednisolone sodium phosphate 1%, moxifloxacin 0.5%, and bromfenac 0.075% ophthalmic solution due to being subpotent.
Imprimis NJOF is recalling 3320 bottles of compounded prednisolone sodium phosphate 1%, moxifloxacin 0.5%, and bromfenac 0.075% ophthalmic solution due to being subpotent.
Imprimis NJOF is recalling 3320...
05/09/2024
Pharmacy Learning Network

Advertisement

News
Obstetric Drug Recalled for Subpotency
05/09/2024
Jolynn Tumolo
Amneal Pharmaceuticals of New York is recalling 2784 bottles of methylergonovine maleate tablets because they are subpotent.
Amneal Pharmaceuticals of New York is recalling 2784 bottles of methylergonovine maleate tablets because they are subpotent.
Amneal Pharmaceuticals of New...
05/09/2024
Pharmacy Learning Network
News
Compounded Eye Injection Recalled
05/09/2024
Jolynn Tumolo
Two lots of compounded epinephrine 0.025% and lidocaine HCl 0.75% intraocular solution for injection are being recalled by Imprimis NJOF. The May 8, 2024, US Food and Drug Administration (FDA) Enforcement Report states the solution is “out of...
Two lots of compounded epinephrine 0.025% and lidocaine HCl 0.75% intraocular solution for injection are being recalled by Imprimis NJOF. The May 8, 2024, US Food and Drug Administration (FDA) Enforcement Report states the solution is “out of...
Two lots of compounded...
05/09/2024
Pharmacy Learning Network
News
COPD Medication Recalled
05/02/2024
Jolynn Tumolo
Cipla USA Inc. is recalling two lots of ipratropium bromide and albuterol sulfate inhalation solution.
Cipla USA Inc. is recalling two lots of ipratropium bromide and albuterol sulfate inhalation solution.
Cipla USA Inc. is recalling two...
05/02/2024
Pharmacy Learning Network

Advertisement

News
Ophthalmic Strips Pulled for Potential Impurities
05/02/2024
Jolynn Tumolo
Nomax Inc. is recalling more than 42,000 cartons of GloStrips and Ful-Glo fluorescein sodium ophthalmic strips because the active pharmaceutical ingredient used in the products failed to meet impurity specifications.
Nomax Inc. is recalling more than 42,000 cartons of GloStrips and Ful-Glo fluorescein sodium ophthalmic strips because the active pharmaceutical ingredient used in the products failed to meet impurity specifications.
Nomax Inc. is recalling more...
05/02/2024
Pharmacy Learning Network
News
Hand Sanitizer, Aloe Gel Under Class I Recall
05/01/2024
Jolynn Tumolo
More than 40 lots of Aruba Aloe Hand Sanitizer Gel and Aruba Aloe Alcoholada Gel are under a Class I recall because they have been found to contain alcohol denatured with methanol.
More than 40 lots of Aruba Aloe Hand Sanitizer Gel and Aruba Aloe Alcoholada Gel are under a Class I recall because they have been found to contain alcohol denatured with methanol.
More than 40 lots of Aruba Aloe...
05/01/2024
Pharmacy Learning Network
News
FDA Proposes New Patient Medication Information Guide to Improve Patient Understanding and Adherence
04/26/2024
Hannah Musick
The FDA proposed introducing a Patient Medication Information (PMI), in addition to the Medication Guide, to provide clear and concise details about prescription medications to improve patient understanding and adherence, ultimately reducing...
The FDA proposed introducing a Patient Medication Information (PMI), in addition to the Medication Guide, to provide clear and concise details about prescription medications to improve patient understanding and adherence, ultimately reducing...
The FDA proposed introducing a...
04/26/2024
Pharmacy Learning Network

Advertisement

News
Subpotent Antibiotic Pulled
04/24/2024
Jolynn Tumolo
Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Lupin Pharmaceuticals Inc. is recalling 26,352 bottles of rifampin capsules because the drug is subpotent, according to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Lupin Pharmaceuticals Inc. is...
04/24/2024
Pharmacy Learning Network
News
Skin Med Recalled for Superpotency
04/24/2024
Jolynn Tumolo
Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...
Teva Pharmaceuticals USA Inc. is recalling a single lot of isotretinoin capsules over concerns of superpotency. According to the April 17, 2024, US Food and Drug Administration (FDA) Enforcement Report, results from 3-month stability testing...
Teva Pharmaceuticals USA Inc. is...
04/24/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use